Assignee
IMMUNWORK INC
TW·19 granted patents·5 pending applications·23 citations·filing 2016–2025
Top patents by PatentIndex Score
24 records- 0191US10010626B2Molecular constructs with targeting and effector moietiesIMMUNWORK INC·Filed 2016·Granted Jul 3, 2018·7 cites·51 claims
- 0287US9623118B2Multi-arm linker constructs for treating pathological blood clotsIMMUNWORK INC·Filed 2016·Granted Apr 18, 2017·5 cites·26 claims
- 0384US9975951B2Peptide core-based multi-arm linkers and their applicationsIMMUNWORK INC·Filed 2016·Granted May 22, 2018·3 cites·26 claims
- 0484US9907858B2Peptide core-based multi-arm linkersIMMUNWORK INC·Filed 2016·Granted Mar 6, 2018·3 cites·33 claims
- 0576US10894091B2Linker units and molecular constructs comprising the sameIMMUNWORK INC·Filed 2018·Granted Jan 19, 2021·1 cites·23 claims
- 0674US9994638B2Peptide core-based multi-arm linkers for treating infectious diseasesIMMUNWORK INC·Filed 2016·Granted Jun 12, 2018·1 cites·18 claims
- 0774US9988454B2Peptide core-based multi-arm linkers for treating central nervous system diseasesIMMUNWORK INC·Filed 2016·Granted Jun 5, 2018·1 cites·17 claims
- 0872US11235064B2Core constructs and their uses in configuring pharmaceutical moleculesIMMUNWORK INC·Filed 2018·Granted Feb 1, 2022·0 cites·19 claims
- 0970US9688776B2Anti-human mIgA antibodies capable of lysing mIgA-B lymphocytes and decreasing IgA productionIMMUNWORK INC·Filed 2016·Granted Jun 27, 2017·2 cites·14 claims
- 1064US10668165B2Molecular constructs for treating tumorsIMMUNWORK INC·Filed 2016·Granted Jun 2, 2020·0 cites·11 claims
- 1163US2024342298A1Methods of treating tumors by using molecular constructIMMUNWORK INC·Filed 2024·Application pending·0 cites
- 1261US11926678B2Composite polypeptide having a metal binding motif and molecular construct comprising the sameIMMUNWORK INC·Filed 2021·Granted Mar 12, 2024·0 cites·4 claims
- 1360US11203614B2Composite polypeptide having a metal binding motif and molecular construct comprising the sameIMMUNWORK INC·Filed 2020·Granted Dec 21, 2021·0 cites·11 claims
- 1460US10383947B2Pharmaceuticals in joint-linker configurations for treating pathological blood clotsIMMUNWORK INC·Filed 2016·Granted Aug 20, 2019·0 cites·25 claims
- 1559US11220680B2Polypeptide for treating pathological blood clotsIMMUNWORK INC·Filed 2019·Granted Jan 11, 2022·0 cites·15 claims
- 1658US10442861B2Molecular constructs with targeting and effector moieties for treating infectious diseasesIMMUNWORK INC·Filed 2016·Granted Oct 15, 2019·0 cites·23 claims
- 1758US10202455B2Molecular constructs with targeting and effector moieties comprising an SCFV specific for ectodomain of transferrin-1 receptor and fingolimodIMMUNWORK INC·Filed 2016·Granted Feb 12, 2019·0 cites·9 claims
- 1852US10993986B2Pharmaceutical constructs with enhanced binding affinity with albuminIMMUNWORK INC·Filed 2020·Granted May 4, 2021·0 cites·15 claims
- 1950US10300104B2Multi-arm linker for treating rejection reaction in transplantationIMMUNWORK INC·Filed 2016·Granted May 28, 2019·0 cites·13 claims
- 2050US10293018B2Fusion protein for treating rejection reaction in transplantationIMMUNWORK INC·Filed 2016·Granted May 21, 2019·0 cites·4 claims
- 2149US2019055195A1Phenyl, bromo-maleimide as a coupling group for conjugation to sulfhydryl groupIMMUNWORK INC·Filed 2018·Application pending·0 cites
- 2247US2025241994A1Pharmaceutical formulation of glucagon-like peptide -1 receptor agonist peptide for sublingual deliveryIMMUNWORK INC·Filed 2025·Application pending·0 cites
- 2346US2018055946A1Versatile peptide-based multi-arm linkers for constructing pharmaceutical moleculesIMMUNWORK INC·Filed 2017·Application pending·0 cites
- 2446US2018110872A1Multi-arm linkers for constructing pharmaceutical moleculesIMMUNWORK INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →